Vertaling van "may be submitted will " (Nederlands → Frans) :

Such risks and uncertainties include, among other things, the uncertainties inherent in research and development; whether and when regulatory authorities in countries where regulatory applications for Prevenar 13 may be pending or may be submitted will approve such applications and their decisions regarding labeling and other matters that could affect its availability or commercial potential; and competitive developments.
This release contains forward-looking information that involves substantial risks and uncertainties regarding Prevenar 13, including its potential benefits; and the success of the AMC project for vaccines. Such risks and uncertainties include, among other things, the uncertainties inherent in research and development; whether and when regulatory authorities in countries where regulatory applications for Prevenar 13 may be pending or may be submitted will approve such applications and their decisions regarding labeling and other matters that could affect its availability or commercial potential; and competitive developments. A further description of risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2009, and in its reports on Form 10-Q and Form 8-K.

Applications for already notified homeopathic medicines will have to be submitted in line with a timetable which will be set by the Minister of Public Health in accordance with article 14 of the royal decree of 23 June 1999.
Applications for already notified homeopathic medicines will have to be submitted in line with a timetable which will be set by the Minister of Public Health in accordance with article 14 of the royal decree of 23 June 1999.

The law of 7 May 2004 relating to experiments on the human person in Belgium provides that any objections from the FAMHP need to be submitted within a maximum of 28 days following the validation of applications for clinical trials.
The law of 7 May 2004 relating to experiments on the human person in Belgium provides that any objections from the FAMHP need to be submitted within a maximum of 28 days following the validation of applications for clinical trials.

The authorities may ask those concerned to submit a local care plan for depression and suicide.
Les autorités peuvent demander aux personnes concernées de soumettre un plan de soins local en matière de dépression et de suicide.

This release contains forward-looking information about an agreement by Pfizer to acquire FoldRx, and about FoldRx’s product candidate tafamidis, its other clinical and preclinical development programs and its technology platform, including their potential benefits, that involves substantial risks and uncertainties. Such risks and uncertainties include, among other things, the satisfaction of conditions to closing the agreement; the uncertainties inherent in research and development; whether and when a new drug application for tafamidis will be filed with the FDA; decisions by regulatory authorities regarding whether and when to approve any drug applications that have been or may be filed for tafamidis and that may be filed for any other product candidates that may be generated by FoldRx’s technology platform as well as their decisions regarding labeling and other matters that could affect the availability or commercial potential of tafamidis and such other product candidates; and competitive developments. A further description of risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2009 and in its reports on Form 10-Q and Form 8-K.
Such risks and uncertainties include, among other things, the satisfaction of conditions to closing the agreement; the uncertainties inherent in research and development; whether and when a new drug application for tafamidis will be filed with the FDA; decisions by regulatory authorities regarding whether and when to approve any drug applications that have been or may be filed for tafamidis and that may be filed for any other product candidates that may be generated by FoldRx’s technology platform as well as their decisions regarding labeling and other matters that could affect the availability or commercial potential of tafamidis and such other product candidates; and competitive developments.

The SOE-USE will also be involved in control policy, and the current demarcation with other inspection units may potentially change.
The SOE-USE will also be involved in control policy, and the current demarcation with other inspection units may potentially change.

The dispatching service will inform the appropriate intervention service (fire brigade, police, medical assistance) but the call-takers may also do the dispatching themselves.
Le dispatching mettra au courant l’intervenant adéquat (pompiers, police, intervention médicale), mais il se peut également que les répondants s’occupent eux-mêmes du dispatching.

In this context, the SOE - USE will then also be involved in control policy, and the current demarcation between this and other inspection services may change.
In this context, the SOE - USE will then also be involved in control policy, and the current demarcation between this and other inspection services may change.

It is these organisations’ experience that these students are not sufficiently aware of how sensitive this topic really is. More precisely, there may be high-risk students in the classroom (i.e. young students with a history of suicidal behaviour or a depression, students who have lost a close relative through suicide…) who will be put in a very difficult position if this topic is broached in an abrupt or ill-considered manner.
Il se peut notamment qu’il y ait des élèves à risque dans la classe (des jeunes avec un comportement suicidaire antérieur, avec une dépression, des élèves qui ont perdu un proche par suicide…) qui auront très difficile si ce thème est abordé en classe de façon imprévoyante et non réfléchie.